Pilot project uses technology to improve resident communication


Thursday, 16 November, 2023


Pilot project uses technology to improve resident communication

Bolton Clarke Research Institute is investigating personal amplification devices, which use digital technology to enhance speech, as a low-cost alternative to hearing aids.

The project is aimed at removing undetected hearing loss as a barrier in assessing cognitive ability.

Bolton Clarke Clinical Nurse Consultant Kylie Walters said hearing difficulties can often mimic dementia or depression, as reduced hearing greatly reduces a client’s ability to communicate.

As a result, the accuracy and understanding of key assessments such as the Rowland Universal Dementia Assessment Scale (RUDAS) and Psychogeriatric Assessment Scales (PAS) can be severely hampered, leading to potentially negative outcomes for clients.

The use of personal amplification devices in assessments has been a simple and positive experience for both clinicians and clients, Walters said.

“Clients wear a set of headphones attached to the device, and the level of amplification is able to be tailored to each individual.

“We have trialled with 10 clients so far and the results have been overwhelmingly positive. During the assessments, both concentration and understanding of questions is improved, with less repetition or stalling for answers,” she said.

Researchers are hoping that after a successful pilot, the devices can become an everyday part of the clinician’s toolbox to support and enhance communication and better target care.

“What is most important is the client’s experience,” Walters said.

“Our clients have already seen the benefits. Their faces light up when they are able to hear clearly, and they feel comfortable and relaxed using the device.”

Image: Supplied.

Related Articles

Arthritis hard facts this Men's Health Week

For Men's Health Week, 9–15 June, Arthritis Australia released some 'hard...

Alzheimer's drug TGA approval "momentous" — but is health care ready?

On 22 May, donanemab became the first drug registered in Australia proven to significantly slow...

Dementia training app adds palliative care course

To mark National Palliative Care Week, Dementia Australia has added a palliative care course to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd